Upstream Biotechnology raised seed funding for ‘on-demand’ crop defense tech; SwitchBlade molecular gate activates plant defenses only at disease or stress sites.

Upstream Biotechnology has raised seed funding to enhance its 'SwitchBlade' technology, which selectively activates plant defenses at sites of disease or stress.¹

“The platform regulates trait activation at the level of protein translation,” said CEO George H. Greene, emphasizing its ability to maintain normal growth under non-stress conditions.

The technology addresses a critical challenge in crop biotechnology: improving disease resistance without the yield penalties often associated with traditional methods.

“When disease or other stressors are detected, the gate is released, allowing the plant to produce the protein and activate its defenses only when needed,” Greene explained.

This localized response prevents yield drag, a common issue with systemic activation methods.

The funding will be used to advance the SwitchBlade platform, expand validation across various crops, and strengthen intellectual property.²³

“We’re providing the ability to fine-tune translational control for precise trait activation, which could drive real value,” Greene noted, highlighting the potential applications for crops like soy, corn, rice, and tomatoes.

Upstream's model involves licensing the technology to seed companies, allowing them to enhance their existing traits based on performance and timing.

“To date, we’ve demonstrated efficacy across multiple row crop systems,” Greene stated, indicating the technology's readiness for broader application.

Upstream's approach is rooted in extensive research and aims to become a key player in crop resilience and disease resistance technologies.